Skip to content

Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors

Laser Therapy on Burned Skin

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04947449
Enrollment
4
Registered
2021-07-01
Start date
2021-07-29
Completion date
2025-03-01
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn Injury

Keywords

laser treatment, laser therapy, skin blood flow, sweating

Brief summary

The purpose of this study is to examine effects of laser therapy on blood flow and sweating responses in burn-injured skin.

Detailed description

This is a longitudinal study in which the effects of laser therapy on cutaneous vascular responses and sweating of the treated areas are assessed. Specifically, burn survivors who will undergo standard of care laser therapy to treat burn-related scars will perform whole-body heating and local heating procedures prior to the initiation of laser therapy, at an intermediate point during the laser therapy regimen, and upon conclusion of the laser therapy regimen. For this pilot investigation a placebo will not be incorporated. Primary outcome variables will be skin blood flow and sweating responses from skin treated with laser therapy and adjacent untreated/uninjured skin.

Interventions

DEVICEfractional CO2 laser

Standard of care laser treatment of burn-related injuries will be performed. This protocol assesses the effects of those treatments on skin blood flow and sweating responses.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* 18-65 years old * Experience a severe burn injury that warrant laser therapy. * Free of any significant underlying medical problems based upon a detailed medical history and physical exam

Exclusion criteria

* Known heart disease * Other chronic medical conditions requiring regular medical therapy including cancer, diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia. * Abnormality detected on routine screening suggestive of cardiac ischemia or previously undetected cardiac disease or resting left bundle branch block on screening electrocardiogram. * Subject with a body mass index \>35 kg/m2 * Pregnant or planning to become pregnant within the subsequent 6 months.

Design outcomes

Primary

MeasureTime frameDescription
Skin blood flowUpwards to 6 months after the final laser treatmentPrimary outcome variables will be skin blood flow and sweating responses from skin treated with laser therapy and adjacent untreated/uninjured skin.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026